Pam Belluck in The New York Times:
A newly developed blood test for Alzheimer’s has diagnosed the disease as accurately as methods that are far more expensive or invasive, scientists reported on Tuesday, a significant step toward a longtime goal for patients, doctors and dementia researchers. The test has the potential to make diagnosis simpler, more affordable and widely available.
The test determined whether people with dementia had Alzheimer’s instead of another condition. And it identified signs of the degenerative, deadly disease 20 years before memory and thinking problems were expected in people with a genetic mutation that causes Alzheimer’s, according to research published in JAMA and presented at the Alzheimer’s Association International Conference. Such a test could be available for clinical use in as little as two to three years, the researchers and other experts estimated, providing a readily accessible way to diagnose whether people with cognitive issues were experiencing Alzheimer’s, rather than another type of dementia that might require different treatment or have a different prognosis. A blood test like this might also eventually be used to predict whether someone with no symptoms would develop Alzheimer’s.
More here.
Enjoying the content on 3QD? Help keep us going by donating now.
If you hear the word Ozempic, weight loss immediately comes to mind. The drug—part of a family of treatments called GLP-1 agonists—took the medical world (and internet) by storm for helping people manage diabetes, lower the risk of heart disease, and rapidly lose weight. The drugs may also protect the brain against dementia. In a clinical trial including over 200 people with mild Alzheimer’s disease, a daily injection of a GLP-1 drug for one year slowed cognitive decline. When challenged with a battery of tests assessing memory, language skills, and decision-making, participants who took the drug remained sharper for longer than those who took a placebo—an injection that looked the same but wasn’t functional. The results are the latest from the 
There’s no question that we love to talk — but how did it happen? Yes, humpback whales sing, vervet monkeys use alarm calls, and bees convey information about food sources through dance, but 
How many clinical-trial studies in medical journals are fake or fatally flawed? In October 2020, John Carlisle reported a startling estimate
Last month, the House of Representatives 
Fact: The Windy City nickname has nothing to do with Chicago’s weather
Like many Alzheimer’s researchers, neurologist Randall Bateman is not prone to effusiveness, having endured disappointments in his field. But he and others have found one big reason to be excited lately. In just a few years, he predicts, there will be a simple blood test for your risk of Alzheimer’s. “Any family doctor will be able to do it.” Bateman, who is at Washington University in St. Louis, Missouri, has been running 
It was once common, in Western societies at least, to think of plants as the passive, inert background to animal life, or as mere animal fodder. Plants could be fascinating in their own right, of course, but they lacked much of what made animals and humans interesting, such as agency, intelligence, cognition, intention, consciousness, decision-making, self-identification, sociality and altruism. However, groundbreaking developments in the plant sciences since the end of the previous century have blown that view out of the water. We are just beginning to glimpse the extraordinary complexity and subtlety of plants’ relations with their environment, with each other and with other living beings. We owe these radical developments in our understanding of plants to one area of study in particular: the study of plant behaviour.
Many entrepreneurs have tried to create prediction markets, contracts that trade on the outcome of future events. Luke Nosek, cofounder of PayPal, once 
As someone trained in physics, and as an academic paid to research, I have been drawn to studying one essential contributor to these crises: how energy and electricity are produced, especially those methods proposed to mitigate climate change. Prominent among these proposals is nuclear energy.
Running a finger over a row of books in a Delhi library one afternoon, I stopped at a title that promised danger. The stacks were abundant in books like RSS Misunderstood and Is RSS the Enemy?, which often turned out to be self-published polemics that were too long, however short they were. This one was different. On its front was the full title, 
Hundreds of millions of people across the globe now earn their living less with their backs and more with their brains, relying on sharp reasoning and creative thinking. So how about seeing who’s best at that?
W
OPEN ANY BOOK BY CAROLINE BLACKWOOD and you will encounter the same woman. Articulate, adrift, callous, cosmically self-absorbed. She’s in the middle of her life, a retired actress or model, once striking and sought-after. Her misery has a predatory quality. Decisions made idly and capriciously she now clings to as essential facets of her “character.” She rebels continually against the restraints and privations she inflicts upon herself. She behaves as though she were onstage, thundering dramatic monologues of deceit and self-justification. What’s clearest is her anger: pure, whole, just beneath the surface, like a calcium deposit under the skin.
At the 1912 Olympic Games in Stockholm, Sweden, Jim Thorpe easily won the decathlon in the first modern version of the event. The grueling, ten-part feat was not the only addition to the burgeoning modern games. Other events that debuted at the 1912 Olympics included architecture, sculpture, painting, music… and literature.